JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
This browser version is no longer supported. Please upgrade to a supported browser.
Learn More
Dismiss
2022_Challenging_Biologicals
Saved to Drive
Slideshow
Sign in
File
Edit
View
Help
Accessibility
Debug
Unsaved changes to Drive
Accessibility
View only
1
©
Jeltsch
Lab
&
UH
Biopharmaceuticals
Challenges
in
formulation,
pro-
duction
and
quality
control
Slide
1
of
45
TMED-929
Michael
Jeltsch,
University
of
Helsinki
&
Wihuri
Research
Institute
17.11.2022
The
most
recent
version
of
this
presentation:
https://mjlab.fi/challenging-biologics
TMED-929
2
©
Jeltsch
Lab
&
UH
Slide
2
of
45
Antibody
fusion
proteins:
Eylea
®
,
OPT-302
PROV-105A
©
Jeltsch
Lab
&
UH
Biopharmaceuticals
Challenges
in
formulation,
pro-
duction
and
quality
control
Slide
1
of
45
TMED-929
Michael
Jeltsch,
University
of
Helsinki
&
Wihuri
Research
Institute
17.11.2022
The
most
recent
version
of
this
presentation:
https://mjlab.fi/challenging-biologics
TMED-929
This slide is skipped in slideshow mode
HTML view of the presentation
Turn on screen reader support
Since you last viewed
Since you last approved
Since approval started
Presenter view
Start slideshow with speaker notes and audience Q&A
Start from beginning
Ctrl+Shift+F5
Present using Chromecast
Presentation display options
New
Search the
m
enus
Alt+/
Slides
H
elp
T
raining
U
pdates
Help Slides imp
r
ove
Report
a
buse
P
rivacy Policy
Term
s
of Service
K
eyboard shortcuts
Ctrl+/
Verbalize to
s
creen reader
►
Go to
f
ilmstrip
Ctrl+Alt+Shift+F
Go to can
v
as
Ctrl+Alt+Shift+C
Go to speaker
n
otes
Ctrl+Alt+Shift+S
C
omments
►
M
isspelling
►
F
o
rmatting
►
Link copied to clipboard
Anyone with the link
Anyone who has the link can access. No sign-in required.
Copy link
Copy link to this time
Quick sharing actions
To enable screen reader support, press Ctrl+Alt+Z To learn about keyboard shortcuts, press Ctrl+slash